UBS Reiterates Neutral Rating on Maravai LifeScience Holdings Inc. (MRVI)

September 9, 2026 6:07 AM

UBS analyst Douglas Schenkel reiterated a Neutral rating and $8.00 price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found